Cepheid
Andrea Mori has extensive accounting experience with over two decades in various leadership roles across multiple organizations. Currently serving as VP, Americas Controller at Cepheid since February 2016, Andrea has previously held positions such as North American Controller and Assistant Controller at the same company. Prior experience includes Director of Accounting at LiveOps, Inc., where responsibilities encompassed managing accounting operations for both U.S. and foreign subsidiaries, and Director of Accounting Operations at CV Therapeutics. Andrea's earlier career includes roles at Connetics Corporation and Alexon, where critical financial functions and reporting were managed. Andrea holds a Bachelor of Science in Accounting from San Jose State University.
This person is not in any offices
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.